- Home
- SOL vs LXEO Comparison
SOL vs LXEO Comparison
Compare SOL & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOL
- LXEO
- Stock Information
- Founded
- SOL 2005
- LXEO 2017
- Country
- SOL United States
- LXEO United States
- Employees
- SOL N/A
- LXEO N/A
- Industry
- SOL Semiconductors
- LXEO
- Sector
- SOL Technology
- LXEO
- Exchange
- SOL Nasdaq
- LXEO Nasdaq
- Market Cap
- SOL 94.9M
- LXEO 93.9M
- IPO Year
- SOL 2008
- LXEO 2023
- Fundamental
- Price
- SOL $1.89
- LXEO $3.91
- Analyst Decision
- SOL Strong Buy
- LXEO Strong Buy
- Analyst Count
- SOL 2
- LXEO 5
- Target Price
- SOL $4.50
- LXEO $16.60
- AVG Volume (30 Days)
- SOL 171.8K
- LXEO 697.6K
- Earning Date
- SOL 05-14-2025
- LXEO 08-11-2025
- Dividend Yield
- SOL N/A
- LXEO N/A
- EPS Growth
- SOL N/A
- LXEO N/A
- EPS
- SOL N/A
- LXEO N/A
- Revenue
- SOL $85,621,000.00
- LXEO N/A
- Revenue This Year
- SOL N/A
- LXEO N/A
- Revenue Next Year
- SOL $45.37
- LXEO N/A
- P/E Ratio
- SOL N/A
- LXEO N/A
- Revenue Growth
- SOL N/A
- LXEO N/A
- 52 Week Low
- SOL $1.04
- LXEO $1.45
- 52 Week High
- SOL $3.00
- LXEO $19.50
- Technical
- Relative Strength Index (RSI)
- SOL 63.87
- LXEO 55.22
- Support Level
- SOL $1.69
- LXEO $3.62
- Resistance Level
- SOL $1.79
- LXEO $4.29
- Average True Range (ATR)
- SOL 0.08
- LXEO 0.45
- MACD
- SOL 0.00
- LXEO 0.04
- Stochastic Oscillator
- SOL 92.59
- LXEO 58.68
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has globalised Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. Majority of revenue is From Electricity Generation. The company operates in China, USA, Germany, UK, Spain, France, Poland, Italy, Hungary, Luxembourg. Majority of revenue is from Italy.
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.